Double Bond Pharmaceutical, DBP, is a pharmaceutical company. The company's business focus is on the treatment of cancer, infections and autoimmune diseases. The research is based on the company's proprietary drug-delivery technology. The products are sold under separate brands and product development collaborations take place with other players in the industry. The company is headquartered in Uppsala.

Quotes for Double Bond Pharmaceutical International AB

Right Now

+/-
-0.01
%
−7,69%
Latest
0.12
High
0.1485
Low
0.1155
Volume
285 641
Turnover (SEK)
35 719
Market Value (MSEK)
24,6
Time (Latest trade)
2025-07-14 17:29

Board

CEO

  • Igor Lokot

Chairperson of the Board

  • Sanna Rejnlander

Board

  • Igor Lokot
  • Irina Zaitseva
  • Sergey Yanitsky

Videos

Largest Owners

Name Capital % Votes % Date
Igor Lokot 9,01 16,06 2025-06-26
KSDR Hamberg AB 7,82 7,21 2025-06-26
Per Ahlström 7,74 7,14 2025-06-26
Carl Carvalho 4,03 3,72 2025-06-26
Lars-Åke Börje Flarke 3,41 3,15 2025-06-26
Avanza Pension 3,01 2,78 2025-06-26
Investentia AB 2,80 2,58 2025-06-26
Magnus Hamberg 2,57 2,37 2025-06-26
Thomas Trumstedt 1,87 1,72 2025-06-26
Georgi Kalbin 1,75 1,61 2025-06-26
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

Key Numbers

*Compiled data from Millistream